Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Day: July 18, 2021

Clinical Trials | Center for Cancer Research,

The CBTC has opened a clinical trial in canine meningioma. Funding for the clinical trial has been generously provided by the American Kennel Club- …, The CBTC has opened a clinical trial in canine meningioma. Funding for the clinical trial has been generously provided by the American Kennel Club- …, Read More

Kazakhstan Approves Russia’s Sputnik Light Vaccine,

The Russian Direct Investment Fund (RDIF), which financed clinical trials of Sputnik Light, said the single-dose vaccine had demonstrated 79.4 …, The Russian Direct Investment Fund (RDIF), which financed clinical trials of Sputnik Light, said the single-dose vaccine had demonstrated 79.4 …, Read More

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE,

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of …, YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United …

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE, Read More »

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE,

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of …, YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United …

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE, Read More »

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE,

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of …, YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United …

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE, Read More »

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE,

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of …, YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United …

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE, Read More »

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE,

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of …, YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United …

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE, Read More »

Scroll to Top